Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya

Author:

Wekesa P.,McLigeyo A.,Owuor K.,Mwangi J.,Ngugi E.

Abstract

Abstract Background Retention of patients who are receiving antiretroviral therapy (ART) remains a challenge especially in the setting of rapid expansion of HIV services. Retention in care remains vital to the HIV care continuum, and has been associated with viral suppression and improved survival. This study aimed to ascertain survival rates, time to loss to follow-up (LTFU) or mortality events and factors associated with time to LTFU or mortality among patients enrolled on antiretroviral therapy at health facilities in central Kenya. Methods This was a retrospective cohort study among patients initiated on ART between 2004 and 2012 in central Kenya. Demographic characteristics, clinical characteristics and outcomes data were analyzed using Stata version 15.1. Competing risks regression analysis and cummulative incidence functions were used to estimate survival. Results A total of 31,346 patients were included, of whom 65.6% were female, 76.0% were aged between 20 and 50 years old, and 38.9% were diagnosed at WHO stage III. At 36 months, overall retention was 68.8%, LTFU was 27.1%, and mortality was 4.1%. The total person-years of follow up was 74,986. The incidence rate of LTFU was 9.99 per 100 person years for a total of 9383.25 person-years of follow up. The mortality rate was 1.25 per 100 person years for a total of 875.5 person-years among those who died. The median time to LTFU was 11 months (IQR 3–22) while median time to death was 3 months (IQR 0–13). Men, unmarried patients, patients presenting with advanced HIV, not on TB treatment, and enrolled into the HIV program in later cohorts, had a shorter time to mortality and LTFU. Conclusion Our study demonstrated evidence of scale-up of HIV treatment programs in central Kenya. While most patients were enrolled at an advanced WHO clinical stage, overall 36-month mortality remained low, but occurred earlier during follow-up. Cohort LTFU at 36-months reduced in later years with the losses occurring within the 1st year of follow-up. Predictors of early mortality and LTFU included being male, single, separated or divorced, advanced WHO clinical stage, and among patients not on TB treatment.

Funder

Centers for Disease Control and Prevention

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Reference54 articles.

1. The Joint United Nations Programme on HIV/AIDS U. Global AIDS update 2016. 2016.

2. United Nations Programme on HIV/AIDS. UNAIDS. UNAIDS data 2021. 2021. p. 4–38.

3. National Aids Control Council. Kenya AIDS strategic framework 2020/21–2024/25. Minist Heal Kenya [Internet]. 2020; Available from: http://nacc.or.ke/wp-content/uploads/2015/09/KASF_Final.pdf.

4. National AIDS and STI Control Programme (NASCOP) Kenya. Kenya AIDS indicator survey 2012: final report. 2014.

5. National AIDS and STI Control Programme (NASCOP). KENPHIA 2018 preliminary report [Internet]. Ministry of Health, Kenya. 2018. Available from: http://link.springer.com/10.1007/978-3-319-59379-1%0A. https://doi.org/10.1016/B978-0-12-420070-8.00002-7%0A. https://doi.org/10.1016/j.ab.2015.03.024%0A. https://doi.org/10.1080/07352689.2018.1441103%0A. http://www.chile.bmw-motorrad.cl/sync/showroom/lam/es/bike/urb.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3